Publication:
Antiviral prophylaxis for varicella zoster in immunocompromised patients (excluding haematological malignancies)

Simple item page
dc.contributor.authorChristina C. Changen_US
dc.contributor.authorAllen C. Chengen_US
dc.contributor.authorRichard J. Maudeen_US
dc.contributor.authorMonica Slavinen_US
dc.contributor.otherMonash Universityen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherPeter Maccallum Cancer Centreen_US
dc.date.accessioned2018-11-23T10:41:25Z
dc.date.available2018-11-23T10:41:25Z
dc.date.issued2015-07-01en_US
dc.description.abstract© 2015 The Cochrane Collaboration. This is the protocol for a review and there is no abstract. The objectives are as follows: To evaluate the effectiveness of antiviral agents as prophylaxis against VZV reactivation in immunosuppressed patients.en_US
dc.identifier.citationCochrane Database of Systematic Reviews. Vol.2015, No.7 (2015)en_US
dc.identifier.doi10.1002/14651858.CD008052.pub2en_US
dc.identifier.issn1469493Xen_US
dc.identifier.other2-s2.0-85041800862en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/36391
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85041800862&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleAntiviral prophylaxis for varicella zoster in immunocompromised patients (excluding haematological malignancies)en_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85041800862&origin=inwarden_US

Files

Collections

Scopus 2011-2015